Don’t forget…Our FAS team can be contacted online with free support advice
Hear from our two AMP 2022 guest speakers about their experience utilizing OGT’s SureSeq™ Myeloid research NGS solutions in their genomic laboratories to detect key aberration in myeloid malignancies, including CEBPA gene variants, FLT3-ITDS and KMT2A-PTDs, among others.
Watch OGT’s recent presentation and hear how our customers, Dr. Peter Sabatini and Dr. Graeme Quest, streamlined their CLL research and utilized OGT’s SureSeq CLL + CNV panel to detect CNVs five chromosomal regions as well as SNVs, and indels in key genes implicated in CLL.
As one of the first steps in many NGS data analysis pipelines, accurate variant calling is often critical to downstream analysis and interpretation. Read OGT’s recent blog to learn more about NGS variant calling best practices.
Learn how CytoSure® Constitutional NGS research solution delivers CNV analysis down to single-exon level and loss of heterozygosity (LOH) as well as SNV and indel detection in intellectual disability and developmental delay (ID/DD) patient samples.
Our hematology troubleshooting tool provides expert guidance on how to identify and resolve these problems to help you get the best results from your FISH probes.
Visit International site
Visit Canada site
International
